Similar articles for PMID: 30042160

Year	Number of Results
1998	1
2003	1
2004	2
2005	1
2006	1
2007	1
2008	2
2009	2
2010	3
2012	3
2013	11
2014	4
2015	9
2016	10
2017	13
2018	16
2019	15
2020	5
2021	5
2022	7
2023	4
2024	1

1

Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of ¹⁸F-Fluoride Metabolic Flux Than with Measurement of ¹⁸F-Fluoride PET/CT SUV?

Azad GK, Siddique M, Taylor B, Green A, O'Doherty J, Gariani J, Blake GM, Mansi J, Goh V, Cook GJR. Azad GK, et al. J Nucl Med. 2019 Mar;60(3):322-327. doi: 10.2967/jnumed.118.208710. Epub 2018 Jul 24. J Nucl Med. 2019. PMID: 30042160 Free PMC article.

2

Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV_max in [¹⁸F]fluoride and [¹⁸F]FDG PET?

Azad GK, Cousin F, Siddique M, Taylor B, Goh V, Cook GJR. Azad GK, et al. Mol Imaging Biol. 2019 Aug;21(4):781-789. doi: 10.1007/s11307-018-1262-3. Mol Imaging Biol. 2019. PMID: 30250989 Free PMC article. Clinical Trial.

3

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

4

Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [¹⁸F] fluorodeoxyglucose and [¹⁸F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging.

Azad GK, Taylor BP, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR. Azad GK, et al. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830. doi: 10.1007/s00259-018-4223-9. Epub 2018 Dec 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30506455 Free PMC article. Clinical Trial.

5

Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, Mankoff DA. Doot RK, et al. J Nucl Med. 2010 Apr;51(4):521-7. doi: 10.2967/jnumed.109.070052. Epub 2010 Mar 17. J Nucl Med. 2010. PMID: 20237040 Free PMC article. Clinical Trial.

6

Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.

Lin C, Bradshaw T, Perk T, Harmon S, Eickhoff J, Jallow N, Choyke PL, Dahut WL, Larson S, Humm JL, Perlman S, Apolo AB, Morris MJ, Liu G, Jeraj R. Lin C, et al. J Nucl Med. 2016 Dec;57(12):1872-1879. doi: 10.2967/jnumed.116.177295. Epub 2016 Jul 21. J Nucl Med. 2016. PMID: 27445292 Free PMC article. Clinical Trial.

7

Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in ¹⁸F-Fluoride PET/CT.

Gomes Marin JF, Duarte PS, Willegaignon de Amorim de Carvalho J, Sado HN, Sapienza MT, Buchpiguel CA. Gomes Marin JF, et al. J Nucl Med Technol. 2019 Mar;47(1):60-63. doi: 10.2967/jnmt.118.215111. Epub 2018 Aug 23. J Nucl Med Technol. 2019. PMID: 30139886 Free article.

8

The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.

Donners R, Tunariu N, Tovey H, Hall E, Chua S, Cook G, Du Y, Blackledge MD, Parker CC, Koh DM. Donners R, et al. Eur Radiol. 2024 Feb;34(2):1146-1154. doi: 10.1007/s00330-023-10172-7. Epub 2023 Aug 24. Eur Radiol. 2024. PMID: 37615760 Free PMC article.

9

Uptake of Radium-223 Dichloride and Early [¹⁸F]NaF PET Response Are Driven by Baseline [¹⁸F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.

Letellier A, Johnson AC, Kit NH, Savigny JF, Batalla A, Parienti JJ, Aide N. Letellier A, et al. Mol Imaging Biol. 2018 Jun;20(3):482-491. doi: 10.1007/s11307-017-1132-4. Mol Imaging Biol. 2018. PMID: 29027074

10

Comparison of [⁶⁸Ga]Ga-PSMA-11 PET/CT with [¹⁸F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.

Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ. Uprimny C, et al. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1873-1883. doi: 10.1007/s00259-018-4048-6. Epub 2018 May 16. Eur J Nucl Med Mol Imaging. 2018. PMID: 29766246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year